JP2016527223A5 - - Google Patents

Download PDF

Info

Publication number
JP2016527223A5
JP2016527223A5 JP2016526557A JP2016526557A JP2016527223A5 JP 2016527223 A5 JP2016527223 A5 JP 2016527223A5 JP 2016526557 A JP2016526557 A JP 2016526557A JP 2016526557 A JP2016526557 A JP 2016526557A JP 2016527223 A5 JP2016527223 A5 JP 2016527223A5
Authority
JP
Japan
Prior art keywords
alkyl
group
groups
optionally
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016526557A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016527223A (ja
JP6491656B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2014/065004 external-priority patent/WO2015007669A1/en
Publication of JP2016527223A publication Critical patent/JP2016527223A/ja
Publication of JP2016527223A5 publication Critical patent/JP2016527223A5/ja
Application granted granted Critical
Publication of JP6491656B2 publication Critical patent/JP6491656B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016526557A 2013-07-17 2014-07-14 新規アザベンズイミダゾール誘導体 Active JP6491656B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13176929 2013-07-17
EP13176929.1 2013-07-17
PCT/EP2014/065004 WO2015007669A1 (en) 2013-07-17 2014-07-14 New azabenzimidazole derivatives

Publications (3)

Publication Number Publication Date
JP2016527223A JP2016527223A (ja) 2016-09-08
JP2016527223A5 true JP2016527223A5 (https=) 2017-07-20
JP6491656B2 JP6491656B2 (ja) 2019-03-27

Family

ID=48790302

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016526557A Active JP6491656B2 (ja) 2013-07-17 2014-07-14 新規アザベンズイミダゾール誘導体

Country Status (20)

Country Link
US (1) US9492436B2 (https=)
EP (1) EP3022210B1 (https=)
JP (1) JP6491656B2 (https=)
KR (1) KR20160033749A (https=)
CN (1) CN105377857B (https=)
AR (1) AR096936A1 (https=)
AU (1) AU2014292236B2 (https=)
CA (1) CA2918401A1 (https=)
CL (1) CL2016000026A1 (https=)
DK (1) DK3022210T3 (https=)
EA (1) EA032195B1 (https=)
ES (1) ES2669543T3 (https=)
HU (1) HUE038261T2 (https=)
MX (1) MX359040B (https=)
PH (1) PH12016500092B1 (https=)
PL (1) PL3022210T3 (https=)
TR (1) TR201806860T4 (https=)
TW (1) TW201546076A (https=)
UY (1) UY35668A (https=)
WO (1) WO2015007669A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016023789A1 (en) * 2014-08-11 2016-02-18 Boehringer Ingelheim International Gmbh Azabenzimidazole derivatives as amp protein kinase agonistes
RU2017107543A (ru) 2014-08-27 2018-10-02 Шионоги Энд Ко., Лтд. Производное азаиндола с аmpk-активирующим действием
CA2965781A1 (en) 2014-10-28 2016-05-06 Shionogi & Co., Ltd. Heterocyclic derivative having ampk activating effect
WO2016113299A1 (en) * 2015-01-16 2016-07-21 Boehringer Ingelheim International Gmbh New azabenzimidazole derivatives
WO2017146186A1 (ja) 2016-02-26 2017-08-31 塩野義製薬株式会社 Ampk活性化作用を有する5-フェニルアザインドール誘導体
CN109476661A (zh) * 2016-05-20 2019-03-15 盐野义制药株式会社 具有ampk活化作用的5-取代苯并咪唑及5-取代氮杂苯并咪唑衍生物
JP2022508751A (ja) * 2018-10-15 2022-01-19 ゲロ ディスカバリー リミテッド ライアビリティ カンパニー Pfkfb3阻害剤とその使用
UY38941A (es) 2019-11-11 2021-06-30 Pi Industries Ltd Nuevas sulfiliminas o sulfoximinas que contienen compuestos heterocíclicos fungicidas
WO2021236617A1 (en) 2020-05-19 2021-11-25 Kallyope, Inc. Ampk activators
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂
CN116368140A (zh) 2020-09-10 2023-06-30 加舒布鲁姆生物公司 杂环glp-1激动剂
CN120957993A (zh) 2023-02-16 2025-11-14 加舒布鲁姆生物公司 杂环glp-1激动剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2043744A2 (en) * 2006-07-13 2009-04-08 SmithKline Beecham Corporation Chemical compounds
WO2012033149A1 (ja) 2010-09-10 2012-03-15 塩野義製薬株式会社 Ampk活性化作用を有するヘテロ環縮合イミダゾール誘導体
SG192941A1 (en) * 2011-02-25 2013-09-30 Merck Sharp & Dohme Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
WO2014031468A1 (en) * 2012-08-22 2014-02-27 Merck Sharp & Dohme Corp. Novel benzimidazole hexahydrofuro[3,2-b]furan derivatives
EP2888005B1 (en) * 2012-08-22 2019-04-03 Merck Sharp & Dohme Corp. Novel azabenzimidazole hexahydrofuro[3,2-b]furan derivatives
WO2014069426A1 (ja) * 2012-10-31 2014-05-08 塩野義製薬株式会社 Ampk活性化作用を有するベンズイミダゾールおよびアザベンズイミダゾール誘導体

Similar Documents

Publication Publication Date Title
JP2016527223A5 (https=)
JP2017523226A5 (https=)
AU2020305979B2 (en) Method for treating idiopathic pulmonary fibrosis
CN104220053B (zh) cAMP直接活化交换蛋白(EPAC)的调节剂
JP2016508506A5 (https=)
KR20170095882A (ko) 트리아졸로피리미딘 화합물 및 그의 용도
TWI510484B (zh) 用於預防及/或治療因化學治療或放射治療所引起之嘔吐的σ配子
JP2008513514A5 (https=)
WO2014168941A1 (en) Formulations of oxabicycloheptanes and oxabicycloheptenes
WO2015106268A1 (en) USE OF sGC STIMULATORS FOR THE TREATMENT OF NEUROMUSCULAR DISORDERS
JP2021505575A5 (https=)
JP2018048143A5 (https=)
WO2011161216A1 (en) Heteroaryl compounds and compositions as protein kinase inhibitors
JP2016515110A5 (https=)
KR20180094965A (ko) 위장 괄약근 기능장애의 치료를 위한 sGC 자극제의 용도
JP2018502133A5 (https=)
JP2012526772A5 (https=)
JP2018502135A5 (https=)
JP2016535049A5 (https=)
US20150087886A1 (en) Novel bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer
JP2007530591A (ja) 双極性障害を治療するための、nk3アンタゴニストの使用
EP2716632A1 (en) Inhibitors of viral replication, their process of preparation and their therapeutical uses
CA2797762A1 (en) Imidazo[1,2-a]pyridine derivative
US20130289047A1 (en) Heteroarylthio derivatives and analogues
JP2011509942A5 (https=)